 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Nabriva Therapeutics plc (NBRV)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-08-19 Sale | 2020-08-21 7:02 pm | Nabriva Therapeutics plc | NBRV | Broom Colin MD Director | 11,064 | $0.6476 | $7,165 | 248,936 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-05-31 Tax Withholding | 2020-06-03 06:06 am | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $1.14 | 179,366 (Direct) | View |
| 2020-05-31 Tax Withholding | 2020-06-03 06:06 am | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $1.14 | 169,046 (Direct) | View |
| 2020-05-31 Tax Withholding | 2020-06-03 06:07 am | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 1,211 | $1.14 | 653,662 (Direct) | View |
| 2020-05-31 Tax Withholding | 2020-06-03 06:07 am | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 628 | $1.14 | 342,205 (Direct) | View |
| 2020-05-31 Tax Withholding | 2020-06-03 06:08 am | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 312 | $1.14 | 199,554 (Direct) | View |
| 2020-06-30 Tax Withholding | 2020-07-02 4:06 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 312 | $0.6746 | 199,242 (Direct) | View |
| 2020-06-30 Tax Withholding | 2020-07-02 4:06 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 1,211 | $0.6746 | 652,451 (Direct) | View |
| 2020-06-30 Tax Withholding | 2020-07-02 4:07 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.6746 | 168,745 (Direct) | View |
| 2020-06-30 Tax Withholding | 2020-07-02 4:07 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $0.6746 | 179,000 (Direct) | View |
| 2020-06-30 Tax Withholding | 2020-07-02 4:08 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 366 | $0.6746 | 197,785 (Direct) | View |
| 2020-06-30 Tax Withholding | 2020-07-02 4:22 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 628 | $0.6746 | 341,577 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 4:53 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Broom Colin MD Director | 17,500 | $0 | 35,000 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 4:53 pm | N/A 2030-07-28 | Nabriva Therapeutics plc | NBRV | Broom Colin MD Director | 35,000 | $0.79 | 35,000 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 4:54 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director | 17,500 | $0 | 35,000 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 4:54 pm | N/A 2030-07-28 | Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director | 35,000 | $0.79 | 35,000 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 4:54 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Talbot George Harrison Director | 17,500 | $0 | 35,000 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 4:54 pm | N/A 2030-07-28 | Nabriva Therapeutics plc | NBRV | Talbot George Harrison Director | 35,000 | $0.79 | 35,000 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 4:55 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director | 17,500 | $0 | 35,000 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 4:55 pm | N/A 2030-07-28 | Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director | 35,000 | $0.79 | 35,000 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 4:55 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Webster Stephen W Director | 17,500 | $0 | 35,000 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 4:55 pm | N/A 2030-07-28 | Nabriva Therapeutics plc | NBRV | Webster Stephen W Director | 35,000 | $0.79 | 35,000 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 4:56 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Bourdow Carrie L. Director | 17,500 | $0 | 35,000 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 4:56 pm | N/A 2030-07-28 | Nabriva Therapeutics plc | NBRV | Bourdow Carrie L. Director | 35,000 | $0.79 | 35,000 (Direct) | View |
| 2020-07-31 Tax Withholding | 2020-08-04 4:07 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 312 | $0.76 | 198,930 (Direct) | View |
| 2020-07-31 Tax Withholding | 2020-08-04 4:08 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 1,211 | $0.76 | 651,240 (Direct) | View |
| 2020-07-31 Tax Withholding | 2020-08-04 4:08 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.76 | 168,444 (Direct) | View |
| 2020-07-31 Tax Withholding | 2020-08-04 4:09 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $0.76 | 178,634 (Direct) | View |
| 2020-07-31 Tax Withholding | 2020-08-04 4:56 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 628 | $0.76 | 340,949 (Direct) | View |
| 2020-07-31 Tax Withholding | 2020-08-04 4:57 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 366 | $0.76 | 197,419 (Direct) | View |
| 2020-08-19 Exercise | 2020-08-21 7:02 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 11,250 | $0 | 0 (Direct) | View |
| 2020-08-19 Tax Withholding | 2020-08-21 7:02 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 3,204 | $0.6476 | 0 (Direct) | View |
| 2020-08-19 Exercise | 2020-08-21 7:02 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 11,250 | $0 | 0 (Direct) | View |
| 2020-08-19 Exercise | 2020-08-21 7:02 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Broom Colin MD Director | 33,750 | $0 | 248,936 (Direct) | View |
| 2020-08-19 Exercise | 2020-08-21 7:02 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Broom Colin MD Director | 33,750 | $0 | 248,936 (Direct) | View |
| 2020-08-19 Exercise | 2020-08-21 7:03 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 11,250 | $0 | 0 (Direct) | View |
| 2020-08-19 Tax Withholding | 2020-08-21 7:03 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 3,759 | $0.6476 | 0 (Direct) | View |
| 2020-08-19 Exercise | 2020-08-21 7:03 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 11,250 | $0 | 0 (Direct) | View |
| 2020-08-19 Exercise | 2020-08-21 7:03 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 11,250 | $0 | 0 (Direct) | View |
| 2020-08-19 Tax Withholding | 2020-08-21 7:03 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 3,759 | $0.6476 | 0 (Direct) | View |
| 2020-08-19 Exercise | 2020-08-21 7:03 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 11,250 | $0 | 0 (Direct) | View |
| 2020-08-19 Exercise | 2020-08-21 7:04 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 11,250 | $0 | 0 (Direct) | View |
| 2020-08-19 Exercise | 2020-08-21 7:04 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 16,000 | $0 | 0 (Direct) | View |
| 2020-08-19 Tax Withholding | 2020-08-21 7:04 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 3,204 | $0.6476 | 0 (Direct) | View |
| 2020-08-19 Tax Withholding | 2020-08-21 7:04 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 4,557 | $0.6476 | 0 (Direct) | View |
| 2020-08-19 Exercise | 2020-08-21 7:04 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 11,250 | $0 | 0 (Direct) | View |
| 2020-08-19 Exercise | 2020-08-21 7:04 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 16,000 | $0 | 0 (Direct) | View |
| 2020-08-31 Tax Withholding | 2020-09-02 5:14 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 366 | $0.6194 | 204,544 (Direct) | View |
| 2020-08-31 Tax Withholding | 2020-09-02 5:15 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 1,211 | $0.6194 | 650,029 (Direct) | View |
| 2020-08-31 Tax Withholding | 2020-09-02 5:15 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.6194 | 168,143 (Direct) | View |
| 2020-08-31 Tax Withholding | 2020-09-02 5:15 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $0.6194 | 185,759 (Direct) | View |
| 2020-08-31 Tax Withholding | 2020-09-02 5:15 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 628 | $0.6194 | 359,810 (Direct) | View |
| 2020-08-31 Tax Withholding | 2020-09-02 5:16 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 312 | $0.6194 | 206,664 (Direct) | View |
| 2020-09-30 Tax Withholding | 2020-10-01 4:30 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 366 | $0.533 | 204,178 (Direct) | View |
| 2020-09-30 Tax Withholding | 2020-10-01 4:30 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 628 | $0.533 | 359,182 (Direct) | View |
| 2020-09-30 Tax Withholding | 2020-10-01 4:30 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $0.533 | 185,393 (Direct) | View |
| 2020-09-30 Tax Withholding | 2020-10-01 4:31 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.533 | 167,842 (Direct) | View |
| 2020-09-30 Tax Withholding | 2020-10-01 4:32 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 1,211 | $0.533 | 648,818 (Direct) | View |
| 2020-09-30 Tax Withholding | 2020-10-01 4:32 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 312 | $0.533 | 206,352 (Direct) | View |